Al-Zoughool Mustafa, Talaska Glenn
Department of Environmental Health, University of Cincinnati College of Medicine, Cincinnati, OH 45267-0056, USA.
Anal Biochem. 2005 May 15;340(2):352-8. doi: 10.1016/j.ab.2005.01.048.
A simple and sensitive method for determination of the N-glucuronidation activity of mouse, rat, and human liver microsomes toward the carcinogenic arylamine 4-aminobiphenyl (4-ABP) using high-performance liquid chromatography with ultraviolet detection has been developed. The method uses chemically synthesized 4-ABP-N-glucuronide (4-ABP-G) as a standard for method validation. Validation was done with respect to specificity, linearity, precision, accuracy, and lower limits of detection. The method was specific since there were no interference peaks from the reaction matrix. The calibration curve for 4-ABP-G was linear from 50 to 5000 pmol/200 microl with R2=0.999. The newly developed method has good precision and accuracy. The intra- and interday precisions were less than 5 and 10%, respectively, and the highest values for intra- and interday accuracies were -4.6 and -12%, respectively. The lower limit of detection was 10 pmol/200 microl. The developed method was used to determine the glucuronidation activity of mouse, rat, and human liver microsomes. Human liver microsomes were the most active in 4-ABP glucuronidation (344.1 pmol/min/mg) followed by rats (30.6 pmol/min/mg) and then mice (12.3 pmol/min/mg). Human UGT1A4 supersomes were much more active than UGT1A9 (184.4 mol/min/mg versus 25.2 mol/min/mg). These results are consistent with those of earlier studies that used the radioactive [C14]UDPGA.
已开发出一种简单且灵敏的方法,使用带紫外检测的高效液相色谱法测定小鼠、大鼠和人肝微粒体对致癌芳胺4-氨基联苯(4-ABP)的N-葡萄糖醛酸化活性。该方法使用化学合成的4-ABP-N-葡萄糖醛酸苷(4-ABP-G)作为方法验证的标准品。针对特异性、线性、精密度、准确度和检测下限进行了验证。该方法具有特异性,因为反应基质没有干扰峰。4-ABP-G的校准曲线在50至5000 pmol/200微升范围内呈线性,R2 = 0.999。新开发的方法具有良好的精密度和准确度。日内和日间精密度分别小于5%和10%,日内和日间准确度的最高值分别为-4.6%和-12%。检测下限为10 pmol/200微升。所开发的方法用于测定小鼠、大鼠和人肝微粒体的葡萄糖醛酸化活性。人肝微粒体在4-ABP葡萄糖醛酸化方面活性最高(344.1 pmol/分钟/毫克),其次是大鼠(30.6 pmol/分钟/毫克),然后是小鼠(12.3 pmol/分钟/毫克)。人UGT1A4超微粒体比UGT1A9活性高得多(184.4摩尔/分钟/毫克对25.2摩尔/分钟/毫克)。这些结果与早期使用放射性[C14]UDPGA的研究结果一致。